Rabies Antiserum Market Roadmap: Strategic Planning for Success
Rabies antiserum is derived from the blood of animals immunized with killed rabies virus and is used to prevent rabies in humans following potential exposure to the virus. It provides passive, short-term immunity until the patient develops their own active immunity by vaccination. The global Rabies Antiserum Market is estimated to be valued at US$ 1.24 billion in 2023 and is expected...
0 Commentarios
0 Acciones